Eradication of Helicobacter pylori in developing countries;Erradicación de Helicobacter pylori en países en desarrollo

Revista Medica de Chile

Volumn 125, Issue 8, 1997, Pages 939-949

  Rollán R, Antonio ^a,b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b NONE   (Chile)

Author keywords

Antibiotics; Helicobacter pylori; Peptic ulcer

Indexed keywords

ANTIINFECTIVE AGENT;

COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DUODENUM ULCER; ECONOMICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; RECURRENT DISEASE; REVIEW;

ANTI-BACTERIAL AGENTS; COST-BENEFIT ANALYSIS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DUODENAL ULCER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; RECURRENCE;

EID: 3242824153     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. MARSHALL BJ. Helicobacter pylori. Am J Gastroenterol 1994; 89: S116-28.
2. NLH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994; 272: 5-09.
3. IARC. Infection with Helicobacter pylori. IARC monographs on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, Liver Flukes and Helicobacter pylori: Vol. 61. Lyon, France: International Agency for Research on Cancer 1994: 177-240.
4. WOTHERSPOON AC, DOGLIONI C, DISS TC, ET AL. Regression of low-grade B-cell gastric lymphoma of MALT type following eradication of Helicobacter pylori. Lancet 1993; 342: 375-7.
5. KUIPERS EJ, THIJS JC, FESTEN HPM. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995; 9; 59-69.
6. HOSKING SW, LING TKW, CHUNG SCS, ET AL. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994; 343: 508-10.
7. HOPKINS RJ, GIRARDI LS, TURNEY EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: A review. Gastroenterology 1996; 110: 1244-52.
8. MISIEWICZ JJ. Helicobacter pylori: Past, Present and Future. Scand J Gastroenterol 1992; 27: 25-9.
9. POUNDER RE, NG D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995; 9: 33-9.
10. HOPKINS RJ, VIAL PA, FERRECCIO C, ET AL. Seroprevalence of Helicobacler pylori in Chile: Vegetables May Serve as One Route of Transmission. J Infect Dis 1993; 168: 222-6.
11. RUSSELL RG, WASSERMAN SS, O'DONNOGHUE M, ET AL. Serological Response to Helicobacter pylori among children and teenagers in northern Chile. Am J Trop Med Hyg 1993; 49: 189-91.
12. PARSONNET J, BLASER MJ, PEREZ-PEREZ GI, ET AL. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologist. Gastroenterology 1992; 102: 41-6.
13. GRAHAM DY. Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J Gastroenterol Hepatol 1991; 6: 105-13.
14. PARSONNET J. The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9: 45-51.
15. CORREA P, SCHMIDT BA. The relationship between gastric cancer and the ratio of gastric to duodenal ulcer. Aliment Pharmacol Ther 1995; 9: 13-19.
16. HANSSON LE, NYREN O, HSING AW, ET AL. The Risk of Stomach Cancer in Patients with Gastric or Duodenal Ulcer Disease. N Engl J Med 1996; 335: 242-9.
17. SONNENBERG A. Temporal trends and geographical variations of peptic ulcer disease. Aliment Pharmacol Ther 1995; 9: 3-12.
18. BLASER J, CHYOU PH, NOMURA A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer and duodenal ulcer risk. Cancer Res 1995; 55: 562-5.
19. PARSONNET J. Helicobacter pylori in the Stomach-A Paradox Unmasked. N Engl J Med 1996; 335: 278-80.
20. KLEIN PD, GILMAN RH, LEON-BARUA R, ET AL. The epidemiology of Helicobacter pylori in Peruvian children between 6 and 30 months of age. Am J Gastroenterol 1994; 89: 2196-200.
21. MENDALL M. Natural history and mode of transmission. In: Northfield TC, Mendall M, Goggin PM (eds). Helicobacter pylori Infection. Pathophysiology, Epidemiology and Management. Vol. 1. Dordrecht: Kluwer Academic Publisher, 1993: 21-32.
22. MALFERTHEINER P. Management of Helicobacter pylori-positive Peptic Ulcer Disease. Scand J Gastroenterol 1996; 31: 69.
23. PENSTON JG. Review article: Helicobacter pylori eradication-understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994; 8: 369-89.
24. GRAHAM DY, LEW GM, MALATY HM, ET AL. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493-6.
25. AXON T. Drugs regimens. In: Northfield TC, Mendall M, Goggin PM, eds. Helicobacter pylori Infection. Pathophysiology, Epidemiology and Management. Vol. 1. Dordrecht: Kluwer Academic Publishers, 1993: 149-57.
26. GLUPCZYNSKY Y, BURETTE A, DE KOSTER E, ET AL. Metronidazole resistance in Helicobacter pylori. Lancet 1990: 976-7.
27. MATISKO A, Thomson ABR. Helicobacter pylori: Beginning the second decade. Can J Gastroenterol 1995; 9: 333-43.
28. FIGUEROA G, ACUÑA R, TRONCOSO M, ET AL. Low H pylori Reinfection Rate after Triple Therapy in Chilean Duodenal Ulcer Patients. Am J Gastroenterol 1996; 91: 1395-9.
29. TYTGAT NJ. Duodenal ulcer disease. Eur J Gastroenterol & Hepatol 1996; 8: 829-33.
30. MOSHKOWITZ M, KONIKOFF FM, PELED Y, ET AL. High Helicobacter pylori numbers are associated with low eradication rate after triple therapy. Gut 1995; 36: 845-7.
31. AXON ATR, MOAYYEDI P. Eradication of Helicobacter pylori: Omeprazole in Combination with Antibiotics. Scand J Gastroenterol 1996; 31: 82-9.
32. LABENZ J, GYENES E, RUHL GH, BORSCH G. Omeprazole Plus Amoxicillin: Efficacy of Various Treatment Regimens to Eradicate Helicobacter pylori. Am J Gastroenterol 1993; 88: 491-5.
33. BAYERDORFER E, MIEHLKE S, MANNES GA, ET AL. Double-Blind Trial of Omeprazole and Amoxicillin to Cure Helicobacter pylori Infection in Patients With Duodenal Ulcers. Gastroenterology 1995; 108: 1412-7.
34. COELHO LGV, PASSOS MCF, CHAUSSON Y, ET AL. Duodenal Ulcer and Eradication of Helicobacter pylori in a Developing Country. Scand J Gastroenterol 1992; 27: 362-6.
35. SIMSEK H, KADAYIFCI A, TATAR G. Low Eradication Rates of Helicobacter pylori with Omeprazole plus Amoxycillin Combination in a Turkish Population (letter). Am J Gastroenterol 1996; 91: 1062.
36. BELL GD, POWELL KU, BURRIDGE SM, ET AL. Reinfection or recrudescence after apparently successful eradication of Helicobacter pylori infection: implications for treatment of patients with duodenal ulcer disease. QJ Med 1993; 86: 375-82.
37. BORODY TJ, ANDREWS P, MANCUSO N, ET AL. Helicobacter pylori reinfection rate in patients with cured duodenal ulcer. Am J Gastroenterol 1994; 89: 529-32.
38. BELL GD. Anti-Helicobacter pylon therapy: clearence, elimination or eradication? Lancet 1991; 337: 310-1.
39. GRAHAM DY, LEW GM, KLEIN PD, ET AL. Effect of treatment of Helicobacter pylon infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Int Med 1992; 116: 705-8.
40. BAYERDORFER E, MANNES GA, SOMMER A, ET AL. Long-Term follow-up after eradication of Helicobacter pylori with a combination of omeprazole and amoxycillin. Scand J Gastroenterol 1993; 28: 19-26.
41. FORBES GM, GLASER ME, CULLEN DJE, ET AL. Duodenal Ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet 1994; 343: 258-60.
42. KLEIN PD, MALATY HM, MARTIN RF, ET AL. Noninvasive Detection of Helicobacter pylori Infection in Clinical Practice: The 14C Urea Breath Test. Am J Gastroenterol 1996; 91: 690-3.
43. BELL GD, POWELL KU. Helicobacter pylori Reinfection after Apparent Eradication- The Ipswich Experience. Scand J Gastroenterol 1996; 31: 96-104.
44. XIA HX, WINDLE HJ, MARSHALL DG, ET AL. Recrudescence of Helicobacter pylori after apparently succesful eradication: novel application of randomly amplified polymorphic DNA fingerprinting. Gut 1996; 37: 30-4.
45. HUA J, BIRAC C, XIA C, ET AL. Differentiation of recrudescence and reinfection during relapse of Helicobacter pylori infection. Am J Gastroenterol 1994; 89: 1295 (Abstract).
46. AKOPYANZ N, BUKANOV NO, WESTBLOM TU, ET AL. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acid Research 1992; 20: 5137-42.
47. SACK RB, GYR K. Helicobacter pylori in developing world. Lancet 1993; 341: 1274-5.
48. COELHO LGV, PASSOA MCF, CHAUSSON Y, ET AL. Long-term results of H pylori treatment in 255 duodenal ulcer patients in Brazil. Am J Gastroenterol 1994; 89: 1367 (Abstract).
49. LABENZ J, TILLENBURG B, PEITZ U, BORSCH G. Long-Term Consequences of Helicobacter pylori Eradication: Clinical Aspects. Scand J Gastroenterol 1996; 31: 111-5.
50. HENTSCHEL E, BRANDSTATTER G, DRAGOSICS B, ET AL. Effect of Ranitidine and Amoxicillin plus Metronidazole on the eradication of Helicobacter pylori and the Recurrence of Duodenal Ulcer. N Engl J Med 1995; 328: 408-12.
51. BIANCHI PORRO G, PARENTE F, LAZZARONI M. Short and long-term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralfate alone. Gut 1993; 34: 466-9.
52. BORODY TJ, ANDREWS P, MANCUSO N, ET AL. Helicobacter pylori reinfection 4 years post-eradication. Lancet 1992: 1295 (letter).
53. CARRICK J, DASKALAPOULOS G, MITCHELL H, ET AL. Successful eradication of Helicobacter pylori infection prevents recurrence of duodenal ulceration. Rev Española Enfermedades Diges 1990; 78 (Suppl 1): 122-3.
54. IMPERIALE TF, SPEROFF T, CEBUL RD, MCCULLOUGH AJ. A Cost Analysis of Alternative Treatments for Duodenal Ulcer. Ann Int Med 1995; 123: 665-72.
55. LOGAN RPH, GUMMET PA, POLSON RJ, ET AL. The recurrence of Helicobacter pylori in relation to duodenal ulcer. Rev Española Enfermedades Diges 1990; 78 (Suppl 1): 72-3.
56. SOLCIA E, FIOCCA R, VILLANI L, ET AL. Effects of Permanent Eradication or Transient Clearence of Helicobacter pylori on Histology of Gastric Mucosa Using Omeprazole With or Without Antibiotics. Scand J Gastroenterol 1996; 31 Suppl 215: 105-10.
57. JÖNSSON B. Cost-efectiveness of Helicobacter pylori Eradication Therapy in Duodenal Ulcer Disease. Scand J Gastroenterol 1996; 31 Suppl 215: 90-5.
58. FENDRICK AM, CHERNEW ME, HIRTH RA, BLOOM BS. Alternative Management Strategies for Patiens with Suspected Peptic Ulcer Disease. Ann Int Med 1995; 123: 260-8.
59. SONNEMBERG A, TOWNSEND WF. Costs of Duodenal Ulcer Therapy With Antibiotics. Arch Intern Med 1995; 155: 922-8.
60. O'BRIEN B, GOEREE R, MOHAMED H, HUNT R. Cost-efectiveness of Helicobacter pylori Eradication for the Long-term Management of Duodenal Ulcer in Canada. Arch Intern Med 1995; 155: 1958-64.
61. FENNERTY MB. Decision Analysis and Helicobacter pylori Ulcer Disease: Powerful Clinical Tool or Potential for Powerful Clinical Error? Gastroenterology 1996; 110: 2118-9.